An impaired transendothelial migration potential of chronic lymphocytic leukemia (CLL) cells can be linked to ephrin-A4 expression

Blood

Volumn 114, Issue 24, 2009, Pages 5081-5090

  Trinidad, Eva M ^a   Ballesteros, Mónica ^b   Zuloaga, Jaime ^c   Zapata, Agustín ^a   Alonso Colmenar, Luis Miguel ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EPHRIN A4; EPHRIN RECEPTOR A2; INTERCELLULAR ADHESION MOLECULE 1; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL ADHESION; CELL MIGRATION; CHEMOTAXIS; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; BIOSYNTHESIS; CONFOCAL MICROSCOPY; ENDOTHELIUM; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; NEUTROPHIL CHEMOTAXIS; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL ADHESION; CHEMOKINE CCL19; CHEMOTAXIS, LEUKOCYTE; ENDOTHELIUM; EPHRIN-A4; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MICROSCOPY, CONFOCAL; RECEPTOR, EPHA2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 73949090085     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-03-210617     Document Type: Article

References (36)

1. Hamblin T. Chronic lymphocytic leukaemia: one disease or two? Ann Hematol. 2002;81(6):299-303.
2. Moreno C, Montserrat E. New prognostic markers in chronic lymphocytic leukemia. Blood Rev. 2008;22(4):211-219.
3. Patten PE, Buggins AG, Richards J, et al. CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment. Blood. 2008;111(10):5173-5181.
4. Soma LA, Craig FE, Swerdlow SH. The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma. Hum Pathol. 2006;37(2):152-159.
5. Ocaña E, Delgado-Perez L, Campos-Caro A, et al. The prognostic role of CXCR3 expression by chronic lymphocytic leukemia B cells. Haematologica. 2007;92(3):349-356.
6. Bürkle A, Niedermeier M, Schmitt-Graff A, Wierda WG, Keating MJ, Burger JA. Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia. Blood. 2007;110(9):3316-3325.
7. López-Giral S, Quintana NE, Cabrerizo M, et al. Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination. J Leukoc Biol. 2004;76(2):462-471.
8. Till KJ, Lin K, Zuzel M, Cawley JC. The chemokine receptor CCR7 and alpha4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes. Blood. 2002;99(8):2977-2984.
9. Vincent AM, Cawley JC, Burthem J. Integrin function in chronic lymphocytic leukemia. Blood. 1996;87(11):4780-4788.
10. Dörmer P, Theml H, Lau B. Chronic lymphocytic leukemia: a proliferative or accumulative disorder? Leuk Res. 1983;7(1):1-10.
11. Bazerbashi MB, Reeve J, Chanarin I. Studies in chronic lymphocytic leukaemia. The kinetics of 51Cr-labelled lymphocytes. Scand J Haematol. 1978;20(1):37-51.
12. Chen JR, Gu BJ, Dao LP, Bradley CJ, Mulligan SP, Wiley JS. Transendothelial migration of lymphocytes in chronic lymphocytic leukaemia is impaired and involved down-regulation of both Lselectin and CD23. Br J Haematol. 1999;105(1):181-189.
13. Hartmann TN, Grabovsky V, Wang W, et al. Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow. Cancer Res. 2009;69(7):3121-3130.
14. Redondo-Muñoz J, Ugarte-Berzal E, Garcia-Marco JA, et al. Alpha4beta1 integrin and 190- kDa CD44v constitute a cell surface docking complex for gelatinase B/MMP-9 in chronic leukemic but not in normal B cells. Blood. 2008;112(1):169-178.
15. Alonso-C LM, Trinidad EM, de Garcillan B, et al. Expression profile of Eph receptors and ephrin ligands in healthy human B lymphocytes and chronic lymphocytic leukemia B-cells. Leuk Res. 2009;33(3):395-406.
16. Pasquale EB. Eph-ephrin bidirectional signaling in physiology and disease. Cell. 2008;133(1):38-52.
17. Pasquale EB. Eph receptor signalling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol. 2005;6(6):462-475.
18. Poliakov A, Cotrina M, Wilkinson DG. Diverse roles of eph receptors and ephrins in the regulation of cell migration and tissue assembly. Dev Cell. 2004;7(4):465-480.
19. Klein R. Eph/ephrin signaling in morphogenesis, neural development and plasticity. Curr Opin Cell Biol. 2004;16(5):580-589.
20. + T lymphocytes stimulates migration and induces tyrosine phosphorylation of PYK2. Blood. 2005;105(7):2869-2876.
21. Sharfe N, Freywald A, Toro A, Dadi H, Roifman C. Ephrin stimulation modulates T-cell chemotaxis. Eur J Immunol. 2002;32(12):3745-3755.
22. Sharfe N, Nikolic M, Cimpeon L, Van De Kratts A, Freywald A, Roifman CM. EphA and ephrin-A proteins regulate integrin-mediated T lymphocyte interactions. Mol Immunol. 2008;45(5):1208-1220.
23. Himanen JP, Nikolov DB. Eph signaling: a structural view. Trends Neurosci. 2003;26(1):46-51.
24. Cowan CA, Henkemeyer M. Ephrins in reverse, park and drive. Trends Cell Biol. 2002;12(7):339-346.
25. Stein E, Lane AA, Cerretti DP, et al. Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses. Genes Dev. 1998;12(5):667-678.
26. Gu B, Dao LP, Wiley J. Impaired transendothelial migration of B-CLL lymphocytes: a defect linked to low L-selectin expression. Leuk Lymphoma. 42(1-2):5-12, 2001.
27. Stauder R, Hamader S, Fasching B, Kemmler G, Thaler J, Huber H. Adhesion to high endothelial venules: a model for dissemination mechanisms in non-Hodgkin's lymphoma. Blood. 1993;82(1):262-267.
28. Himanen JP, Saha N, Nikolov DB. Cell-cell signaling via Eph receptors and ephrins. Curr Opin Cell Biol. 2007;19(5):534-542.
29. Davy A, Soriano P. Ephrin signaling in vivo: look both ways. Dev Dyn. 2005;232(1):1-10.
30. Moss A, Alvares D, Meredith-Middleton J, et al. Ephrin-A4 inhibits sensory neurite outgrowth and is regulated by neonatal skin wounding. Eur J Neurosci. 2005;22(10):2413-2421.
31. Chan B, Sukhatme VP. Receptor tyrosine kinase EphA2 mediates thrombin-induced upregulation of ICAM-1 in endothelial cells in vitro. Thromb Res. 2009;123(5):745-752.
32. Ivanov AI, Romanovsky AA. Putative dual role of ephrin-Eph receptor interactions in inflammation. IUBMB Life. 2006;58(7):389-394.
33. Carman CV, Sage PT, Sciuto TE, et al. Transcellular diapedesis is initiated by invasive podosomes. Immunity. 2007;26(6):784-797.
34. Himanen JP, Nikolov DB. Eph receptors and ephrins. Int J Biochem Cell Biol. 2003;35(2):130-134.
35. Hattori M, Osterfield M, Flanagan JG. Regulated cleavage of a contact-mediated axon repellent. Science. 2000;289(5483):1360-1365.
36. Messmer BT, Messmer D, Allen SL, et al. In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J Clin Invest. 2005;115(3):755-764.